Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Eurasian Journal of Medicine and Oncology Pub Date : 2023-01-01 DOI:10.14744/ejmo.2023.48337

Caglar Unal

引用次数: 0

Abstract

Objectives: This study aimed to evaluate the clinical outcomes, including progression-free survival (PFS), overall survival (OS), Objective Response Rate (ORR)

查看原文本刊更多论文

评估黄体-177 DOTATATE肽受体放射性核素治疗(PRRT)对转移性神经内分泌肿瘤的临床影响:来自 rkiye的多中心真实世界数据

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Eurasian Journal of Medicine and Oncology

CiteScore

5.60

自引率

0.00%

发文量